Dodge & Cox Sanofi Transaction History

Dodge & Cox

$163 Billion
Q1 2024

A detailed history of Dodge & Cox transactions in Sanofi stock. As of the latest transaction made, Dodge & Cox holds 78,125,609 shares of SNY stock, worth $3.79 Billion. This represents 2.32% of its overall portfolio holdings.

Number of Shares

78,125,609

Previous 78,250,193 0.16%

Holding current value

$3.79 Billion

Previous $3.89 Billion 2.43%

% of portfolio

2.32%

Previous 2.59%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$45.75 - $52.48 $5.7 Million - $6.54 Million	-124,584 Reduced 0.16%	78,125,609 $3.8 Billion
Q4 2023 Feb 15, 2024	SELL	$43.13 - $54.79 $11.1 Million - $14.2 Million	-258,279 Reduced 0.33%	78,250,193 $3.89 Billion
Q3 2023 Nov 14, 2023	SELL	$50.95 - $55.2 $101 Million - $110 Million	-1,991,902 Reduced 2.47%	78,508,472 $4.21 Billion
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $102 Million - $115 Million	-2,016,952 Reduced 2.44%	80,500,374 $4.34 Billion
Q1 2023 May 12, 2023	SELL	$45.86 - $54.45 $76.7 Million - $91 Million	-1,671,748 Reduced 1.99%	82,517,326 $4.49 Billion

Q4 2022 Feb 14, 2023	BUY	$38.86 - $48.55 $332 Million - $415 Million	8,538,408 Added 11.29%	84,189,074 $4.08 Billion
Q3 2022 Nov 10, 2022	SELL	$37.22 - $100.5 $50.1 Million - $135 Million	-1,346,616 Reduced 1.75%	75,650,666 $2.88 Billion
Q2 2022 Aug 12, 2022	SELL	$48.99 - $57.46 $735 Million - $862 Million	-15,009,442 Reduced 16.31%	76,997,282 $3.85 Billion
Q1 2022 May 13, 2022	SELL	$48.48 - $53.65 $67.6 Million - $74.9 Million	-1,395,325 Reduced 1.49%	92,006,724 $4.72 Billion
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $33.8 Million - $37.6 Million	-718,017 Reduced 0.76%	93,402,049 $4.68 Billion
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $1.14 Billion - $1.27 Billion	23,839,518 Added 33.92%	94,120,066 $4.54 Billion
Q2 2021 Aug 13, 2021	BUY	$49.36 - $54.25 $60.2 Million - $66.1 Million	1,219,164 Added 1.77%	70,280,548 $3.7 Billion
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $1.32 Billion - $1.47 Billion	29,056,975 Added 72.63%	69,061,384 $3.42 Billion
Q4 2020 Feb 11, 2021	BUY	$45.3 - $51.62 $28.6 Million - $32.6 Million	631,476 Added 1.6%	40,004,409 $1.94 Billion
Q3 2020 Nov 13, 2020	SELL	$49.47 - $53.77 $13.2 Million - $14.4 Million	-267,403 Reduced 0.67%	39,372,933 $1.98 Billion
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $370 Million - $453 Million	-8,622,856 Reduced 17.87%	39,640,336 $2.02 Billion
Q1 2020 May 14, 2020	SELL	$38.02 - $51.66 $410 Million - $557 Million	-10,791,101 Reduced 18.27%	48,263,192 $2.11 Billion
Q4 2019 Feb 13, 2020	SELL	$44.25 - $50.86 $80.3 Million - $92.2 Million	-1,813,701 Reduced 2.98%	59,054,293 $2.96 Billion
Q3 2019 Nov 13, 2019	BUY	$40.34 - $46.64 $6.2 Million - $7.17 Million	153,657 Added 0.25%	60,867,994 $2.82 Billion
Q2 2019 Aug 13, 2019	BUY	$40.43 - $44.3 $5.01 Million - $5.48 Million	123,798 Added 0.2%	60,714,337 $2.63 Billion
Q1 2019 May 14, 2019	BUY	$40.83 - $45.43 $8.75 Million - $9.74 Million	214,367 Added 0.36%	60,590,539 $2.68 Billion
Q4 2018 Feb 14, 2019	SELL	$41.48 - $45.59 $30.5 Million - $33.5 Million	-734,368 Reduced 1.2%	60,376,172 $2.62 Billion
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $9.93 Million - $11.1 Million	-248,230 Reduced 0.4%	61,110,540 $2.73 Billion
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $5.79 Million - $6.34 Million	-153,770 Reduced 0.25%	61,358,770 $2.45 Billion
Q1 2018 May 14, 2018	SELL	$38.98 - $45.76 $22.1 Million - $26 Million	-567,814 Reduced 0.91%	61,512,540 $2.47 Billion
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $4.4 Million - $5.2 Million	-102,727 Reduced 0.17%	62,080,354 $2.67 Billion
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $2.93 Billion - $3.13 Billion	62,183,081	62,183,081 $3.1 Billion

Others Institutions Holding SNY

# of Institutions

756

Shares Held

236M

Call Options Held

1.27M

Put Options Held

1.57M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account